Rod Jackson

Q: What Schools Are Affiliated With Rod Jackson

Rod Jackson is affiliated with the following schools: University of Sydney, University of Auckland

Rod Jackson 's AcademicInfluence.com Rankings

Rod Jackson

Medical

#2751

Historical Rank

Epidemiology

#459

Historical Rank

medical Degrees

Download Badge

Medical

Rod Jackson 's Degrees

Bachelors Biomedical Science University of Auckland
Masters Epidemiology University of Auckland
PhD Epidemiology University of Auckland

Why Is Rod Jackson Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Rodney Thornton Jackson is a New Zealand medically trained epidemiologist who has had lead roles in publicly funded research focussing on systems to effectively identify risk factors in the epidemiology of chronic diseases, in particular cardiovascular diseases . This involved linking large cohort studies to regional and national electronic health databases and enabling the generation of new risk-prevention equations using web-based tools, such as the PREDICT model, to implement, monitor and improve risk assessment and management guidelines. Research on asthma in which Jackson participated influenced decisions made by the New Zealand Ministry of Health, and he has contributed to public debate on dietary risk factors for heart attacks and strokes. Following an evidence-based approach to identification of disparities in medical outcomes for different groups within the New Zealand population, Jackson took a position on racism in the medical sector. In 2020, he became a frequent commentator in the media on the approach of the New Zealand government to the COVID-19 pandemic. Since 1999, Jackson has been professor of epidemiology at the University of Auckland.

(See a Problem?)

Rod Jackson 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants (2016) (3648)
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants (2017) (1563)
Driver sleepiness and risk of serious injury to car occupants: population based case control study (2002) (751)
PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDY (1989) (626)
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants (2021) (585)
Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk (2005) (519)
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data (2014) (449)
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions (2019) (423)
Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. (2004) (386)
A case-control study of deaths from asthma. (1986) (384)
Passive smoking as well as active smoking increases the risk of acute stroke (1999) (351)
Underestimation of relative weight by use of self-reported height and weight. (1987) (343)
The role of driver sleepiness in car crashes: a systematic review of epidemiological studies. (2001) (307)
Rising rural body-mass index is the main driver of the global obesity epidemic in adults (2019) (300)
Mortality from asthma: a new epidemic in New Zealand (1982) (266)
International trends in asthma mortality: 1970 to 1985. (1988) (257)
Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys (2019) (253)
Updated New Zealand cardiovascular disease risk-benefit prediction guide (2000) (246)
Effect of environmental factors on risk of injury of child pedestrians by motor vehicles: a case-control study (1995) (238)
Management of raised blood pressure in New Zealand: a discussion document. (1993) (235)
Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. (2015) (221)
Motorcycle rider conspicuity and crash related injury: case-control study (2004) (214)
Alcohol consumption and risk of coronary heart disease. (1991) (196)
Guidelines for clinical guidelines (1998) (184)
Indigenous disparities in disease-specific mortality, a cross-country comparison: New Zealand, Australia, Canada, and the United States. (2004) (179)
Non‐steroidal anti‐inflammatory drugs and prostate cancer progression (1998) (177)
End of the New Zealand asthma mortality epidemic (1995) (177)
An International Randomised Placebo-Controlled Trial of a Four-Component Combination Pill (“Polypill”) in People with Raised Cardiovascular Risk (2011) (154)
Guidelines on preventing cardiovascular disease in clinical practice (2000) (151)
Student engagement in very large classes: the teachers’ perspective (2010) (147)
Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study (2018) (144)
Alcohol and ischaemic heart disease: probably no free lunch (2005) (140)
Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants (2020) (138)
A systematic review of epidemiological studies investigating risk factors for work-related road traffic crashes and injuries (2008) (138)
Increasing age and experience: are both protective against motorcycle injury? A case-control study (2000) (136)
Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care (2014) (132)
Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81. (1984) (128)
Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies (2018) (115)
The GATE frame: critical appraisal with pictures (2006) (112)
The burden of death, disease, and disability due to alcohol in New Zealand. (2005) (111)
Lessons from the national asthma mortality study: circumstances surrounding death. (1987) (109)
Cigarette smoking and risk of premature stroke in men and women. (1986) (105)
The Contribution of Alcohol to Serious Car Crash Injuries (2004) (102)
Sex differences in case fatality before and after admission to hospital after acute cardiac events: analysis of community based coronary heart disease register (1996) (98)
Patients Prefer Pictures to Numbers to Express Cardiovascular Benefit From Treatment (2008) (95)
Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice (2008) (94)
Effect of a Computer-Guided, Quality Improvement Program for Cardiovascular Disease Risk Management in Primary Health Care: The Treatment of Cardiovascular Risk Using Electronic Decision Support Cluster-Randomized Trial (2015) (93)
Alcohol, cardiovascular diseases and all causes of death: a review of the epidemiological evidence. (1992) (85)
Alcohol consumption and risk of coronary heart disease. (1991) (85)
Ethnic and socioeconomic disparities in the prevalence of cardiovascular disease in New Zealand. (2008) (82)
Motorcycle engine size and risk of moderate to fatal injury from a motorcycle crash. (2000) (82)
Association of environmental tobacco smoke exposure with socioeconomic status in a population of 7725 New Zealanders. (1998) (81)
Should the first priority in cardiovascular risk management be those with prior cardiovascular disease? (2008) (79)
Cohort Profile: The PREDICT Cardiovascular Disease Cohort in New Zealand Primary Care (PREDICT-CVD 19). (2015) (70)
Motor vehicle driver injury and socioeconomic status: a cohort study with prospective and retrospective driver injuries (2003) (69)
Risk of disability due to car crashes: a review of the literature and methodological issues. (2004) (68)
Driveway-related child pedestrian injuries: a case-control study. (1995) (68)
Beyond hypertension toward guidelines for cardiovascular risk reduction. (2004) (67)
Ethnic differences in the prevalence of new and known diabetes mellitus, impaired glucose tolerance, and impaired fasting glucose. Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand. (2007) (65)
Does recent alcohol consumption reduce the risk of acute myocardial infarction and coronary death in regular drinkers? (1992) (65)
Declining rates of coronary heart disease in New Zealand and Australia, 1983-1993. (1997) (63)
Alcohol and exercise in myocardial infarction and sudden coronary death in men and women. (1987) (61)
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data (2018) (59)
Driver sleepiness and risk of motor vehicle crash injuries: A population-based case control study in Fiji (TRIP 12)☆ (2014) (59)
Alcohol consumption guidelines: relative safety vs absolute risks and benefits (1995) (58)
Alcohol consumption and blood pressure. (1985) (57)
Beta agonists and asthma mortality: déjà vu (1992) (56)
‘Your Heart Forecast’: a new approach for describing and communicating cardiovascular risk? (2010) (56)
Rapid reduction in coronary risk for those who quit cigarette smoking (1998) (55)
The All New Zealand Acute Coronary Syndrome Quality Improvement Programme: Implementation, Methodology and Cohorts (ANZACS-QI 9). (2016) (55)
Validation of a three-month physical activity recall questionnaire with a seven-day food intake and physical activity diary. (1991) (54)
Will screening individuals at high risk of cardiovascular events deliver large benefits? Yes (2008) (53)
Comparison of different markers of socioeconomic status with cardiovascular disease and diabetes risk factors in the Diabetes, Heart and Health Survey. (2008) (52)
Fletcher Challenge-University of Auckland Heart & Health Study: design and baseline findings. (1995) (51)
Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT CVD-1). (2006) (50)
Understanding the new HbA1c units for the diagnosis of Type 2 diabetes. (2012) (50)
Burden of road traffic injuries and related risk factors in low and middle-income Pacific Island countries and territories: a systematic review of the scientific literature (TRIP 5) (2012) (49)
Cardiovascular risk prediction: are we there yet? (2007) (48)
A population-based cohort study of longer-term changes in health of car drivers involved in serious crashes. (2006) (48)
The role of alcohol in unintentional falls among young and middle-aged adults: a systematic review of epidemiological studies (2009) (48)
Random errors in the measurement of 10 cardiovascular risk factors (2004) (47)
Assessing Māori/non-Māori differences in cardiovascular disease risk and risk management in routine primary care practice using web-based clinical decision support: (PREDICT CVD-2). (2007) (46)
Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10. (2010) (46)
Motor vehicle driver injury and marital status: a cohort study with prospective and retrospective driver injuries (2004) (46)
Prevalence of driver sleepiness in a random population-based sample of car driving. (2001) (45)
Hypertension guidelines: criteria that might make them more clinically useful. (2002) (44)
Is body mass index a risk factor for motor vehicle driver injury? A cohort study with prospective and retrospective outcomes. (2003) (44)
IMProving Adherence using Combination Therapy (IMPACT): design and protocol of a randomised controlled trial in primary care. (2011) (43)
Trends in dietary fat and cigarette smoking and the decline in coronary heart disease in New Zealand. (1987) (43)
Ethnic differences in cardiovascular disease risk factors and diabetes status for Pacific ethnic groups and Europeans in the Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand. (2008) (42)
Zero end-digit preference in recorded blood pressure and its impact on classification of patients for pharmacologic management in primary care - PREDICT-CVD-6. (2007) (41)
Framingham Heart Study risk equation predicts first cardiovascular event rates in New Zealanders at the population level. (2003) (41)
Trends in coronary heart disease event rates in New Zealand. (1984) (40)
Differences in patterns of alcohol consumption between Maori and non-Maori in Aotearoa (New Zealand). (2003) (40)
The contribution of alcohol to falls at home among working-aged adults. (2008) (39)
Metabolic syndrome prevalence in a multicultural population in Auckland, New Zealand. (2007) (35)
Explaining trends in coronary heart disease hospitalisations in New Zealand: trend for admissions and incidence can be in opposite directions (2008) (35)
Deaths from lung cancer and ischaemic heart disease due to passive smoking in New Zealand. (1989) (35)
Cardiovascular medications in primary care: treatment gaps and targeting by absolute risk. (2005) (34)
Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy (2018) (34)
Socioeconomic distribution of smoking in a population of 10,529 New Zealanders. (1997) (34)
Trends in coronary heart disease risk factors in Auckland 1982-94. (1995) (34)
One in four major ischaemic heart disease events are fatal and 60% are pre-hospital deaths: a national data-linkage study (ANZACS-QI 8) (2015) (34)
Overweight and obesity prevalence among adult Pacific peoples and Europeans in the Diabetes Heart and Health Study (DHAHS) 2002-2003, Auckland New Zealand. (2010) (34)
Prediction of cardiovascular disease risk among people with severe mental illness: A cohort study (2019) (33)
Ethnic differences and recent trends in coronary heart disease incidence in New Zealand. (1996) (33)
Maintenance of statin use over 3 years following acute coronary syndromes: a national data linkage study (ANZACS-QI-2) (2014) (32)
QRISK or Framingham for predicting cardiovascular risk? (2009) (32)
Blood pressure lowering and cardiovascular risk – Authors' reply (2014) (32)
Guidelines for managing raised blood pressure (1996) (31)
Gender differences in ischaemic heart disease mortality and risk factors in 46 communities: an ecologic analysis (1997) (31)
Effect of age, gender, ethnicity, socioeconomic status and region on dispensing of CVD secondary prevention medication in New Zealand: the Atlas of Health Care Variation CVD cohort (VIEW-1). (2014) (31)
Discrepancies in predicted fracture risk in elderly people (2013) (31)
Dietary intakes of European, Māori, Pacific and Asian adults living in Auckland: the Diabetes, Heart and Health Study (2008) (31)
Asthma deaths in New Zealand. (1992) (31)
Secular trends in underreporting of cigarette consumption. (1985) (30)
Will a web-based cardiovascular disease (CVD) risk assessment programme increase the assessment of CVD risk factors for Maori? (2006) (30)
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight (2020) (30)
The determinants of fat intake in a multi-ethnic New Zealand population. Fletcher Challenge--University of Auckland Heart and Health Study Management Committee. (1998) (30)
Trends in major cardiovascular risk factors in Auckland, New Zealand: 1982 to 2002-2003. (2006) (30)
Evidence-based management of dyslipidaemia (1995) (29)
Sudden death in runners. (1983) (29)
Blood pressure prevalences and levels for a multicultural population in Auckland, New Zealand: results from the Diabetes, Heart and Health Survey 2002/2003. (2006) (29)
Guidelines for detection and management of dyslipidaemia. Scientific Committee of the National Heart Foundation of New Zealand. (1993) (29)
First and recurrent ischaemic heart disease events continue to decline in New Zealand, 2005–2015 (2017) (28)
Trends in hospital admission rates and drug treatment of asthma in New Zealand. (1983) (28)
Death from asthma in Auckland: circumstances and validation of causes. (1984) (28)
Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study (2019) (28)
A comparative analysis of the cardiovascular disease risk factor profiles of Pacific peoples and Europeans living in New Zealand assessed in routine primary care: PREDICT CVD-11. (2010) (28)
Alcohol consumption and its contribution to the burden of coronary heart disease in middle-aged and older New Zealanders: a population-based case-control study. (2004) (27)
Twenty‐eight day and one‐year case fatality after hospitalisation with an acute coronary syndrome: a nationwide data linkage study (2014) (27)
Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers. (2006) (27)
The burden of modifiable cardiovascular risk factors in the coronary care unit by age, ethnicity, and socioeconomic status--PREDICT CVD-9. (2008) (27)
The New Zealand Blood Donors' Health Study: baseline findings of a large prospective cohort study of injury (2002) (27)
Gaps in primary care documentation of cardiovascular risk factors. (2008) (27)
Constructing whole of population cohorts for health and social research using the New Zealand Integrated Data Infrastructure (2018) (26)
Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16 (2014) (26)
Ethnic differences in blood pressure: findings from the Fletcher Challenge-Auckland University Heart and Health Study. (1996) (26)
Validation of coronary heart disease death certificate diagnoses. (1988) (26)
Revisiting the “Christmas Holiday Effect” in the Southern Hemisphere (2016) (25)
Car colour and risk of car crash injury: population based case control study (2003) (25)
High level of capture of coronary intervention and associated acute coronary syndromes in the all New Zealand acute coronary syndrome quality improvement cardiac registry and excellent agreement with national administrative datasets (ANZACS-QI 25). (2019) (25)
The GATE frame: critical appraisal with pictures. (2006) (24)
Trends in ischaemic heart disease: patterns of hospitalisation and mortality rates differ by ethnicity (ANZACS-QI 21). (2018) (23)
Light to Moderate Alcohol Consumption Is Protective for Type 2 Diabetes Mellitus in Normal Weight and Overweight Individuals but Not the Obese (2014) (23)
Developing and validating a cardiovascular risk score for patients in the community with prior cardiovascular disease (2017) (23)
Hospitalisations and deaths due to unintentional falls at home among working-aged New Zealanders. (2007) (22)
Four out of ten patients are not taking statins regularly during the 12 months after an acute coronary event (2012) (22)
Risk‐factor levels and mortality of ischaemic heart disease in three Australasian centres (1988) (22)
Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease (2019) (22)
Sociodemographic differences in prevalence of diagnosed coronary heart disease in New Zealand estimated from linked national health records. (2011) (20)
Modelling the potential impact of population-wide and targeted high-risk blood pressure-lowering strategies on cardiovascular disease in China (2009) (20)
Per capita sugar consumption is associated with severe childhood asthma: an ecological study of 53 countries. (2010) (20)
Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15). (2011) (20)
Differences in health-related socioeconomic characteristics among Pacific populations living in Auckland, New Zealand. (2006) (20)
Is serum urate causally associated with incident cardiovascular disease? (2013) (20)
The relationship between alcohol and coronary heart disease: is there a protective effect? (1993) (19)
Discriminative ability of a risk-prediction tool derived from the Framingham Heart Study compared with single risk factors. (2003) (19)
Preventing coronary heart disease (2006) (19)
Nationwide trends in acute coronary syndrome by subtype in New Zealand 2006–2016 (2019) (18)
Blood pressure levels and the treatment of hypertension in Auckland, 1982. (1983) (18)
Ethnic Differences in Coronary Revascularisation following an Acute Coronary Syndrome in New Zealand: A National Data-linkage Study (ANZACS-QI 12). (2016) (18)
Mortality from coronary heart disease and incidence of acute myocardial infarction in Auckland, Newcastle and Perth (1991) (18)
The accuracy of ethnicity data in primary care and its impact on cardiovascular risk assessment and management--PREDICT CVD-8. (2008) (18)
Is the pharmacological treatment of mild to moderate hypertension cost effective in stroke prevention? (1988) (17)
Trends in coronary heart disease mortality and morbidity in Auckland, New Zealand, 1974-1986. (1990) (16)
A decade of intensive care unit trauma admissions in Auckland. (2000) (16)
Impact of cigarette smoking on the relationship between body mass index and coronary heart disease: a pooled analysis of 3264 stroke and 2706 CHD events in 378579 individuals in the Asia Pacific region (2009) (16)
Markedly different clustering of CVD risk factors in New Zealand Indian and European people but similar risk scores (PREDICT‐14) (2012) (16)
Analysis of predicted coronary heart disease risk in England based on Framingham study risk appraisal models published in 1991 and 2000 (2002) (15)
Trends in cardiovascular risk factors in Auckland, 1982 to 1987. (1990) (15)
Recent trends in asthma mortality, morbidity, and management in New Zealand. (1989) (15)
Cardiovascular disease risk factors in 65-84 year old men and women: results from the Auckland University Heart and Health Study 1993-4. (1998) (15)
Trends in three-year survival following acute myocardial infarction, 1983-1992. (1999) (14)
Replacing sugar-based soft drinks with sugar-free alternatives could slow the progress of the obesity epidemic: have your Coke and drink it too. (2003) (14)
CHD in Australia and New Zealand. (1989) (14)
Trends and determinants of blood pressure in Auckland, New Zealand 1982-94. (1996) (14)
Serum lipid levels for a multicultural population in Auckland, New Zealand: results from the Diabetes Heart and Health Survey (DHAH) 2002-2003. (2007) (14)
Vascular risk calculators: essential but flawed clinical tools? (2013) (14)
Migraine: a risk factor for motor vehicle driver injury? (1997) (14)
The future of population registers: linking routine health datasets to assess a population's current glycaemic status for quality improvement (2014) (14)
Beyond disease burden: towards solution-oriented population health (2013) (13)
A population-based approach to the estimation of diabetes prevalence and health resource utilisation. (2010) (13)
Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study (2021) (13)
Which hypertensive patients should be treated? (1994) (13)
Chronic Obstructive Pulmonary Disease and Lung Cancer in New Zealand (2003) (13)
Using Directed Acyclic Graphs for Investigating Causal Paths for Cardiovascular Disease (2013) (13)
Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention (2019) (13)
Prediction is difficult, particularly about the future. (2007) (13)
A comparative analysis of cardiovascular disease risk profiles of five Pacific ethnic groups assessed in New Zealand primary care practice: PREDICT CVD-13. (2010) (13)
Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus. (2008) (13)
Ethnic differences in cardiovascular risk profiles among 475,241 adults in primary care in Aotearoa, New Zealand. (2020) (13)
Longitudinal deprivation trajectories and risk of cardiovascular disease in New Zealand (2018) (13)
HbA1c in relation to incident diabetes and diabetes-related complications in non-diabetic adults at baseline. (2017) (13)
The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5). (2007) (13)
Proposed new industry code on unhealthy food marketing to children and young people: will it make a difference? (2017) (12)
Patient preference for autonomy: does it change as risk rises? (2011) (12)
White cell count in the normal range and short-term and long-term mortality: international comparisons of electronic health record cohorts in England and New Zealand (2017) (12)
The GATE frame: critical appraisal with pictures (2006) (12)
Can traditional risk factors explain the higher risk of cardiovascular disease in South Asians compared to Europeans in Norway and New Zealand? Two cohort studies (2017) (12)
Development and validation of alternative cardiovascular risk prediction equations for population health planning: a routine health data linkage study of 1.7 million New Zealanders. (2018) (11)
Cardiovascular disease and alcohol consumption: evidence of benefit from epidemiological studies (1994) (11)
The Auckland heart study: a case-control study of coronary heart disease (1989) (11)
The diet of Auckland men and women aged 25-64 years. (1991) (11)
Estimating diabetes prevalence in South Auckland: how accurate is a method that combines lists of linked health datasets? (2010) (11)
Alcohol cardio-protection has been talked up. (2009) (11)
A review of the uses and reliability of food balance sheets in health research. (2020) (11)
Can the incidence and prevalence of coronary heart disease be determined from routinely collected national data? Population‐based estimates for New Zealand in 2001‐03 (2008) (11)
Is estimating lifetime cardiovascular risk useful? (2010) (10)
Reimbursement of pharmaceuticals in New Zealand: comments on PHARMAC's processes. (2000) (10)
'From Kava to Lager'--alcohol consumption and drinking patterns for older adults of Pacific ethnic groups, and Europeans in the Diabetes Heart and Health Study (DHAHS) 2002-2003, Auckland New Zealand. (2009) (10)
Should identical CVD risks in young and old patients be managed identically? Results from two models (2012) (10)
A prospective cohort study of blood donors: methodological issues in the investigation of injuries and chronic diseases (1998) (10)
Assessing 10-year coronary heart disease risk in people with Type 2 diabetes mellitus: Framingham versus United Kingdom Prospective Diabetes Study (2014) (10)
Identification, risk assessment, and management of patients with atrial fibrillation in a large primary care cohort. (2018) (10)
PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations (2022) (10)
Performance of a Framingham cardiovascular risk model among Indians and Europeans in New Zealand and the role of body mass index and social deprivation (2018) (10)
Prevalence of sleepiness while driving four-wheel motor vehicles in Fiji: a population-based survey (TRIP 9) (2013) (10)
Trends in length of stay following acute coronary syndrome hospitalisation in New Zealand 2006-2016: ANZACS-QI 32 study. (2020) (10)
Can the prevalence of diagnosed diabetes be estimated from linked national health records? The validity of a method applied in New Zealand. (2011) (10)
Balancing research for new risk factors and action for the prevention of chronic diseases. (2003) (10)
UNDERTREATMENT AND ASTHMA DEATHS (1985) (9)
Asthma mortality in New Zealand: a review with some policy implications. (1987) (9)
Comparison of event rates among three MONICA centres. (2009) (9)
Quantifying the effect of age on short-term and long-term case fatality in 14000 patients with incident cases of cardiovascular disease (2008) (9)
Risk factors for coronary heart disease: a case-control study. (1985) (9)
‘Should we reconsider the role of age in treatment allocation for primary prevention of cardiovascular disease?’ No, but we can improve risk communication metrics (2016) (9)
Ethnic differences in case fatality following an acute ischaemic heart disease event in New Zealand: ANZACS-QI 13 (2016) (9)
What are the implications for the community of the discrepancy between the theory and practice of BP control? (1995) (9)
Coronary artery bypass graft surgery in New Zealand's Auckland region: a comparison between the clinical priority assessment criteria score and the actual clinical priority assigned. (2006) (8)
Myocardial infarction and sudden death in Auckland. (1984) (8)
Developing a synthetic national population to investigate the impact of different cardiovascular disease risk management strategies: A derivation and validation study (2017) (8)
Acknowledging and acting on racism in the health sector in Aotearoa New Zealand. (2020) (8)
An observational study of how clinicians use cardiovascular risk assessment to inform statin prescribing decisions. (2017) (8)
Coronary heart disease mortality, morbidity, and risk factor trends in New Zealand. (1985) (8)
The distribution and frequency of blood lipid testing by sociodemographic status among adults in Auckland, New Zealand. (2015) (8)
The DANish Comorbidity Index for Acute Myocardial Infarction (DANCAMI): Development, Validation and Comparison with Existing Comorbidity Indices (2020) (8)
Lifetime risk: does it help to decide who gets statins and when? (2014) (7)
Dietary guidelines on trial: the charges are not evidence based (2016) (7)
DRIVER SLEEPINESS AND RISK OF MOTOR VEHICLE CRASH INJURIES: A POPULATION-BASED CASE CONTROL STUDY IN FIJI (2012) (7)
Statistical testing and estimation in medical research. (1988) (7)
Death and injury on roads (2006) (7)
Oxprenolol in Parkinson's disease. (1971) (7)
Cardiovascular mortality in New Zealand and Australia 1968-1983: how can the diverging trends be explained? (1986) (7)
Trends in cardiovascular outcomes after acute coronary syndrome in New Zealand 2006–2016 (2020) (6)
Are the new Lipid Management Guidelines good for Australia's health? (2001) (6)
Prevalence of risk and protective factors for falls in the home environment in a population‐based survey of young and middle‐aged adult New Zealanders (2010) (6)
On Meat, Butter, and Fudge (2019) (6)
Beta-agonists and death from asthma. (1992) (6)
Trends in antihypertensive medication costs in a cohort of Aucklanders 1982-87. (1989) (6)
End of New Zealand asthma epidemic (1995) (6)
Alcohol, cardiovascular diseases and total mortality: the epidemiological evidence. (1991) (6)
Which elderly patients should be considered for anti-hypertensive treatment? An evidence-based approach (1998) (6)
INCREASING AGE AND EXPERIENCE: PROTECTIVE AGAINST MOTORCYCLE INJURIES? (1998) (6)
of the New Zealand Medical Association (2000) (6)
Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk. (2017) (6)
Nationally linked data to improve health services and policy (2019) (6)
Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50%: A population‐based nested case–control study (2021) (6)
The case for improving road safety in Pacific Islands: a population‐based study from Fiji (TRIP 6) (2012) (6)
The Auckland diet: results from a seven day food diary. (1991) (5)
New Zealand guidelines for the management of dyslipidaemia: implications for treatment in an urban New Zealand population. (1996) (5)
Equity of Access to CVD Risk Management Using Electronic Clinical Decision Support in the Coronary Care Unit (2010) (5)
Serum lipids, body mass, and exercise levels in Auckland, 1982. (1986) (5)
General practitioner diagnosis and management of acute knee injuries: summary of an evidence-based guideline. (2007) (5)
Guideline for the diagnosis and management of hypertension in adults — 2016 (2017) (5)
Completeness of ANZACS-QI Cardiac Implanted DEVICE Registry and agreement with national datasets: ANZACS-QI 30. (2019) (5)
occupants: population based case control study Driver sleepiness and risk of serious injury to car (2005) (5)
How do cardiovascular risk prediction equations developed among 30–74 year olds perform in older age groups? A validation study in 125 000 people aged 75–89 years (2020) (5)
Is general practice identification of prior cardiovascular disease at the time of CVD risk assessment accurate and does it matter? (2018) (5)
Contrasting Trends in Acute Coronary Syndrome Hospitalisation and Coronary Revascularisation in New Zealand 2006-2016: A National Data Linkage Study (ANZACS-QI 27). (2019) (5)
The validity of Maori hospital discharge statistics for ischaemic heart disease in New Zealand. (1994) (5)
Ten‐year trends in cardiac implantable electronic devices in New Zealand: a national data linkage study (ANZACS‐QI 51) (2020) (5)
Development and validation of a cardiovascular risk score for patients in the community after acute coronary syndrome (2019) (5)
Inequity in one-year mortality after first myocardial infarction in Māori and Pacific patients: how much is associated with differences in modifiable clinical risk factors? (ANZACS-QI 49). (2020) (4)
Diet, serum cholesterol and the prevention of coronary heart disease in New Zealand. (1988) (4)
Patterns of Drinking and Estimates of Alcohol-Related Mortality in New Zealand (2005) (4)
Attributing risk to hypertension: what does it mean? (2009) (4)
Beta agonists and asthma mortality: déjà vu (1991) (4)
Audit of health data captured routinely in primary healthcare for the clinical decision support system PREDICT (PREDICT CVD-4) (2008) (4)
Predicting cardiovascular risk from national administrative databases using a combined survival analysis and deep learning approach (2020) (4)
Chewing the saturated fat: we still shouldn't. (2015) (4)
Cardiovascular risk factors and their associations with alcohol consumption: are there differences between Maori and non-Maori in Aotearoa (New Zealand)? (2006) (4)
Non-fatal work-related motor vehicle traffic crash injuries in New Zealand: analysis of a national claims database. (2007) (4)
Cardiovascular medication changes over 5 years in a national data linkage study: implications for risk prediction models (2018) (4)
Dietary Intakes by Different Markers of Socioeconomic Status: A Cross-Sectional Study (2014) (4)
Prevention and control of hypertension in New Zealand: a reappraisal. (1988) (3)
Cardiovascular preventive pharmacotherapy stratified by predicted cardiovascular risk: a national data linkage study. (2021) (3)
Prediction of first cardiovascular disease event in 2.9 million individuals using Danish administrative healthcare data: a nationwide, registry-based derivation and validation study (2021) (3)
The Prevalence of Cardiovascular Risk Factors in Different Occupational Groups in New Zealand. (2020) (3)
Are NZ Guideline Adjustments to Framingham Scores Justified for CVD Risk Prediction (2007) (3)
Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice? (2021) (3)
Unwarranted variation in healthcare organisation and practice for long-term conditions. (2011) (3)
What next for education in evidence-based healthcare? A call for submissions (2019) (3)
Coke's anti-obesity campaign: a FIZZ or not? (2013) (3)
Patterns in the drug treatment of hypertension in Auckland, 1982-7. (1989) (3)
Diverging global trends in heart disease and diabetes: implications for dietary guidelines. (2015) (3)
Cardiovascular risk prediction in healthy older people (2021) (3)
Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33) (2019) (3)
The burden of coronary heart disease in Māori: population‐based estimates for 2000‐02 (2009) (3)
Ischaemic Heart Disease and Occupational Exposures: A Longitudinal Linkage Study in the General and Māori Populations of New Zealand (2021) (3)
Unintentional Falls at Home among Working-aged Adults: Methodology and Population Control Selection for a Case-control Study (2008) (3)
Danish Evaluation of Your Heart Forecast (DANY): study protocol for a cluster randomised controlled trial on an interactive risk-communication tool aimed at improving adherence of patients with high blood pressure (2020) (2)
Trends in Ischaemic Heart Disease in Australia, 2001-2015: A Comparison of Urban and Rural Populations. (2021) (2)
Cardiovascular disease risk profile tools and New Zealand--absolutely the best way forward. (2010) (2)
Association between gout and cardiovascular outcomes in adults with no history of cardiovascular disease: large data linkage study in New Zealand (2022) (2)
TRENDS IN ACUTE CORONARY SYNDROME INCIDENCE, INVASIVE MANAGEMENT AND MORTALITY OUTCOMES IN NEW ZEALAND 2006-2016: A NATIONAL ANZACS-QI DATA LINKAGE STUDY (2019) (2)
Asthma mortality. (1985) (2)
A unified national cardiovascular disease (CVD) risk generator is required to address equity in the management of CVD risk in clinical practice in New Zealand. (2019) (2)
Decision-making in an era of cancer prevention via aspirin: New Zealand needs updated guidelines and risk calculators. (2016) (2)
The effect of removing funding restrictions for atorvastatin differed across sociodemographic groups among New Zealanders hospitalised with cardiovascular disease: a national data linkage study. (2016) (2)
Circulating cardiac biomarkers improve risk stratification for incident cardiovascular disease in community dwelling populations (2022) (2)
Both incidence and prevalence of ischaemic heart disease are declining in parallel: a national data-linkage study in New Zealand (ANZACS-QI 52). (2020) (2)
Cigarette smoking andrisk ofpremature stroke inmenandwomen (1986) (2)
Alcohol consumption and risk of coronary heart disease: Authors' reply (1991) (2)
Explaining Recent Trends in Coronary Heart Diseases Hospitalisations in New Zealand: 1993–2005 (2007) (2)
injury: case-control study Motorcycle rider conspicuity and crash related (2005) (2)
FIZZ: a new advocacy group to FIght Sugar in Soft-drinks. (2013) (2)
THE ROLE OF FATIGUE IN CAR CRASHES: A SYSTEMATIC REVIEW (1998) (2)
Blood pressure changes over 7 years in a large workforce cohort in New Zealand. (2006) (2)
Identifying High‐Risk Patients (2009) (2)
End of New Zealand asthma epidemic. (1995) (2)
Quantifying the effect of age on short and long term case fatality in 14,000 patients with incident cardiovascular disease (2008) (2)
Regional variation in cardiac implantable electronic device implants trends in New Zealand over the past decade (ANZACS‐QI 54) (2020) (2)
Management of raised blood pressure. (1994) (2)
Driver Sleepiness and the Risk of Car Crash Injuries: The Auckland Car Crash Injury Study (2001) (1)
Primary prevention of cardiovascular disease: the absolute-risk-based approach (2007) (1)
Removal of Special Authority requirements for clopidogrel improved optimal care following percutaneous coronary intervention across sociodemographic groups. (2015) (1)
EVIDENCE-BASED MANAGEMENT OF DSYLIPIDAEMIA (1995) (1)
Mortality fromasthma: a new epidemic inNewZealand (1982) (1)
Predicting cardiovascular disease risk across the atherosclerotic disease continuum. (2020) (1)
Risk Stratification: A Practical Guide for Clinicians. Miller CC, Reardon MJ, Safi HJ. Cambridge: Cambridge University Press, 2001, pp. 188, (PB) £25.95 ISBN: 0-521-66945-6. (2004) (1)
Alcohol and ischaemic heart disease – Authors' reply (2006) (1)
The importance of blood pressure thresholds versus predicted cardiovascular risk on subsequent rates of cardiovascular disease: a cohort study in English primary care (2022) (1)
A Predictive Model of the Health Benefits and Cost Effectiveness of Celiprolol and Atenolol in Primary Prevention of Cardiovascular Disease in Hypertensive Patients (1997) (1)
Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease? (2018) (1)
The role of driver sleepiness in motor vehicle crash injuries in Fiji (2012) (1)
Authors reply: Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50% (2022) (1)
Performance of CVD risk equations for older patients assessed in general practice: a cohort study. (2020) (1)
A decade of ICU trauma admissions in Auckland, New Zealand (2000) (1)
Atrial Fibrillation in New Zealand Primary Care (2016) (1)
The Excess Burden of Coronary Disease in New Zealand Maori: Incidence, Prevalence and Survival (2009) (1)
Accuracy of Asthma Mortality in France (1990) (1)
P3621Epidemiology of acute coronary syndrome by subtype in New Zealand 2006–2016: an ANZACS-QI nationwide linkage study of hospitalisation, procedures and case fatality (2019) (1)
Primary prevention of cardiovascular events. (2001) (1)
Teaching epidemiology in Australia and New Zealand: What are the core and advanced concepts for epidemiological practitioners and researchers? (2015) (1)
Sheffield risk and treatment table for primary prevention of coronary heart disease (1996) (1)
Developing Non-Laboratory Cardiovascular Risk Assessment Charts and Validating Laboratory and Non-Laboratory-Based Models (2021) (1)
A longitudinal linkage study of occupation and ischaemic heart disease in the general and Māori populations of New Zealand (2022) (1)
Risk of major bleeding by ethnicity and socioeconomic deprivation among 488,107 people in primary care: a cohort study (2020) (1)
375 HYPERTENSION HAS BEEN DEAD FOR OVER 20 YEARS - WHY HAS IT GONE UNNOTICED BY SO MANY CLINICIANS? (2012) (0)
Prevalence of driving while sleepy: a population-based survey of four-wheeled motor vehicle drivers in Fiji (2012) (0)
Asthma deaths. (1982) (0)
Guideline-Directed Medical Therapy Before and After Primary Prevention Implantable Cardioverter Defibrillator Implantation in New Zealand (ANZACS-QI 66). (2022) (0)
The ‘Endgame’ for sugar sweetened beverages (2012) (0)
Cardiovascular risk management series: 3 Identifying high-risk patients (2009) (0)
Rationale, design and population description of the CREDENCE study: cardiovascular risk equations for diabetes patients from New Zealand and Chinese electronic health records (2021) (0)
Reducing hyperlipidaemia. (1988) (0)
P1546Suboptimal management of cardiovascular risk among people with atrial fibrillation - an opportunity for improvement? (2017) (0)
Ten year trends in cardiac implantable electronic devices in New Zealand: a national data linkage study (ANZACS-QI 51). (2020) (0)
Beyond Framingham risk equations: How can cardiovascular risk be estimated when treatment changes over time? (2015) (0)
Investigating the Association Between Alcohol and Falls at Home: A Comparison of Casecontrol and Case-crossover Methods (2006) (0)
Diminishing benefits of urban living for children and adolescents’ growth and development (2023) (0)
QRISK or Framingham for predicting cardiovascular risk? QRISK is better on every performance measure, and should be recommended in the UK (2009) (0)
IMPROVED RISK ASSESSMENT FOR PATIENTS WITH PRIOR CARDIOVASCULAR DISEASE IN THE COMMUNITY: NEW PROGNOSTIC MODELS BASED ON ROUTINELY COLLECTED DATA (2015) (0)
Coronary Heart Disease Incidence, Prevalence and Survival Among The Maori Population, 2000–2002 (2009) (0)
Coronary Heart Disease in New Zealand 2001–2003: Estimates of Incidence and Prevalence Based on Routinely Collected Data (2008) (0)
HAZARDOUS JOURNEYS. CAR COLOUR AND RISK OF CAR CRASH INJURY: POPULATION BASED CASE CONTROL STUDY (2003) (0)
Authors’ reply to McCloskey and colleagues (2013) (0)
What should be done about hypercholesterolaemia? (1988) (0)
Constructing comprehensive population cohorts for health and social research using the New Zealand Integrated Data Infrastructure (IDI) (2017) (0)
Development and Validation of a Risk Score for Patients Back in the Community After an Acute Coronary Syndrome Event (2018) (0)
P5828Stroke and cardiovascular outcomes for patients with atrial fibrillation in the community - an opportunity for improvement? (2017) (0)
Cardiovascular disease preventive medication dispensing for almost every New Zealander 65 years and over: a preventive treatment paradox? (2022) (0)
Increases in early discharge following acute coronary syndrome hospitalisations and associated clinical outcomes in New Zealand between 2006 and 2015: ANZACS‐QI‐43 study (2020) (0)
To the Editor (1991) (0)
Pharmaceutical company sponsorship. (1993) (0)
Ethnic variation in implantable cardioverter defibrillator implant trends in New Zealand 2005–2019 (2021) (0)
Should Left Ventricular Hypertrophy Diagnosed by Echocardiography be Incorporated into Cardiovascular Risk Assessment among Patients with Type 2 Diabetes (2008) (0)
O6C.2 Differences in cardiovascular risk factor profiles across occupational groups (2019) (0)
EDITORIAL Current management of hepatitis C in New Zealand (2001) (0)
From Connor and Colleagues (2004) (0)
Managing cardiovascular disease risk in hypertension – Authors’ reply (2020) (0)
Occupational groups and ischaemic heart disease in New Zealand – a longitudinal linkage study (2020) (0)
AUTHORS' REPLY (1992) (0)
FENOTEROL AND ASTHMA MORTALITY (1989) (0)
P3404Inequality in 5-year risk of coronary heart disease within a low-risk country in the face of equal access to healthcare: a Danish nationwide study (2017) (0)
Control of hypertension. (1988) (0)
Abstract P053: Glycated Hemoglobin in Relation to Incident Diabetes and Cardiovascular Disease in Non-diabetic Adults (2016) (0)
Content Modelling for VIEW Datasets Using Archetypes (2012) (0)
One in four major ischaemic heart disease events are fatal and 60% are pre-hospital deaths: a national data-linkage study (ANZACS-QI 8). (2015) (0)
Cardiac risk assessment--10 year or lifelong? (1995) (0)
Cardiovascular preventive strategies are not conflicting (2020) (0)
Use of the Framingham Score in Predicting CVD for Primary Care Patients With, and Without, a History of CVD (2007) (0)
Integrating EBM into the Undergraduate Medical Curriculum (2016) (0)
Ethnic Differences in Cardiovascular Outcomes in New Zealand: What can we do to Achieve Equity? (2019) (0)
Drugs for asthma in New Zealand, Australia, and the United Kingdom (1984) (0)
Hold the Butter: Preventing Heart Disease in New Zealand (2009) (0)
Danish Evaluation of Your Heart Forecast (DANY) - Study Protocol for a Cluster Randomised Controlled Trial on an Interactive Risk-communication Tool aimed at improving High Blood Pressure Patients’ adherence. (2019) (0)
Evidence-based practice and the individual (2005) (0)
Ethnic variation in the trends of new implantable cardioverter defibrillator implants in New Zealand 2005-2019 (ANZACS-QI 63). (2021) (0)
The Heart Forecaster—Integrating absolute, relative and long-term CVD risk to support risk communication (2009) (0)
The impact of a cardiovascular risk awareness campaign on statin prescribing – good news / bad news (2011) (0)
Electronic Clinical Decision Support in Primary Care: Assessing CVD Risk, Profiling Population Risk Burden and Integrating Risk Prediction Research (2006) (0)
SHOULD YOU LEAVE A LEGACY? POTENTIAL EFFECTS OF DELAYED BLOOD PRESSURE LOWERING PHARMACOTHERAPY IN INDIVIDUALS STRATIFIED BY ABSOLUTE CARDIOVASCULAR DISEASE RISK (2016) (0)
THE ESTIMATED INCIDENCE AND PREVALENCE OF CORONARY HEART DISEASE IN NEW ZEALAND FOR 2001–2003 BASED ON ROUTINELY COLLECTED DATA (2008) (0)
Rethinking the treatment of mild hypertension. (1988) (0)
Stroke and Cardiovascular Outcomes for Patients With Atrial Fibrillation in the Community – An Opportunity for Improvement? (2017) (0)
The evidence to support commonly recommended life-style modifications for control of blood pressure is weak. Weight reduction stands out as a simple but potentially useful intervention (1999) (0)
EDITORIALS Funding health services for older people Richard (2002) (0)
The Framingham score and New Zealand Guidelines adjustments: useful for CVD risk prediction in NZ? (2007) (0)
Pre-event Cardiovascular Risk in Coronary Care Unit Patients (2009) (0)
PCV19: DISCRIMINABILITY FOR RISK OF CARDIOVASCULAR EVENTS (2001) (0)
What proportion of deaths from ischaemic heart disease occur pre-hospital? An ANZACS-QI national data-linkage study (2015) (0)
Comparison of fasting glucose, and HbA1c for use in screening for Type 2 diabetes (2016) (0)
Control of hypertension. (1988) (0)
Prevention of CHD: implications of the Framingham study coronary risk appraisal models published in 1991 and 2000 [Conference presentation] (2002) (0)
Poor Initiation and Persistence with Statins After Hospitalisation for Acute Ischaemic Heart Disease Episodes is Common, Particularly in Patients not Admitted on Statins (2010) (0)
Identifying major risk factors for serious injury: Report on the first prospective linkage of the New Zealand Blood Donors Health Study. (2006) (0)
313Long-acting bronchodilators and risk of acute coronary syndrome (2021) (0)
Rethinking mild hypertension. (1988) (0)
Family History of Premature CVD as an Independent Predictor of Ischaemic CVD Events (2011) (0)
Abstract P331: Ethnic Differences in Glycoslation Indices in Non-Diabetic Adults: The Diabetes, Heart and Health Survey (2015) (0)
Cardiovascular Mortality Prediction for Those with a Prior Cardiovascular Event—The PREDICT Secondary Equation (2011) (0)
Debate: To treat or not to treat mild hypertension (2000) (0)
Erratum: What next for education in evidence-based healthcare? A call for submissions (BMJ Evidence-Based Medicine (2020) 25 (1-2.) DOI: 10.1136/bmjebm-2019-111301) (2020) (0)
USE OF ANTIASTHMATIC DRUG IN AUSTRALIA. AUTHOR'S REPLY (1991) (0)
Abstract P230: Measures of Glycaemia (Fasting and 2 hr Glucose, Glycosylated Haemoglobin) in Relation to Incident Vascular Disease in Non-diabetic Adults (2014) (0)
PCV18: FRAMINGHAM RISK EQUATIONS PREDICT HOSPITAL USAGE AND MORTALITY (2001) (0)
Recurrent Ischaemic Heart Disease Hospitalisations in New Zealand are Declining More Rapidly than First Hospitalisations: An ANZACS-QI National Data-Linkage Study (2016) (0)
Ethnic-Specific Cardiovascular Disease Risk Prediction Scores (2019) (0)
Management of patients with dyslipidaemia. (1995) (0)
Alcohol consumption and the risk of fall injury among young and middle-aged adults : summary of epidemiological evidence Study Participants Exposures Outcomes (2009) (0)
The Heart Forecast Tool-Integrating Absolute, Relative Risk and Long-Term CVD Risk to Support Risk Communication and Behaviour Change (2009) (0)
A Century of Asthma Mortality (2020) (0)
British Medical Journal (1876) (0)
retrospective driver injuries status: a cohort study with prospective and Motor vehicle driver injury and socioeconomic (2005) (0)
Length of Acute Coronary Syndrome Hospitalisation in New Zealand 2006–2016: An All New Zealand Acute Coronary Syndrome-Quality Improvement National Data Linkage Study of Patterns and Predictors (2019) (0)

This paper list is powered by the following services:

Other Resources About Rod Jackson

en.wikipedia.org

What Schools Are Affiliated With Rod Jackson ?

Rod Jackson is affiliated with the following schools:

Rod Jackson 's Academic­Influence.com Rankings